{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-26-000093","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-06-12T21:00:17+00:00","discovered_at":"2026-06-12T21:02:00.231051+00:00","generated_at":"2026-06-12T21:04:09.183743+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"BioRestorative Therapies extends VP R&D Silva's employment; $575K salary unchanged, term to June 2029","bullets":["New employment agreement for VP R&D Francisco Silva, effective June 10, 2026, with term through June 10, 2029.","Salary remains at $575,000 per year; eligible for annual discretionary bonus up to 50% of salary.","On termination without cause or resignation for good reason, severance equals 1.5x (salary + max bonus), plus COBRA paid for 1.5 years, and full vesting of equity awards.","Non-compete and non-solicitation covenants apply for 1 year post-termination within US in stem-cell based therapies and biocosmeceuticals.","Agreement includes assignment of all developments and inventions related to company's business as work made for hire."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-26-000093","json":"https://secwatch.observer/filing/0001021771-26-000093.json","markdown":"https://secwatch.observer/filing/0001021771-26-000093.md","text":"https://secwatch.observer/filing/0001021771-26-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000093/0001021771-26-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000093/brtx-20260612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:04:09.183743+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}